Research / NVDA / Fundamental state Inspectable configuration
State dimensions Filing 0001045810-25-000023 General Corporate
Debt relative to revenue 0th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.debt_to_revenue
6.49% · OPTIONAL · VALID
Capex intensity 38th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.48% · OPTIONAL · VALID
Operating cash generation 88th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
49.11% · OPTIONAL · VALID
Revenue growth 71th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
114.20% · CORE · VALID
Inventory pressure 0th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
7.72% · OPTIONAL · VALID
Gross margin 89th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
74.99% · CORE · VALID
Operating margin 94th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
62.42% · CORE · VALID
R&D intensity 6th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
9.90% · OPTIONAL · VALID
SBC intensity 6th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.63% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Oct 31, 2021 0/9 normalized Level 3 Jan 30, 2022 0/8 normalized Level 3 May 1, 2022 0/8 normalized Level 3 Jul 31, 2022 6/8 normalized Level 3 Oct 30, 2022 7/8 normalized Level 3 Jan 29, 2023 7/8 normalized Level 3 Apr 30, 2023 7/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Oct 29, 2023 8/8 normalized Level 3 Jan 28, 2024 8/9 normalized Level 3 Apr 28, 2024 8/9 normalized Level 3 Jul 28, 2024 8/9 normalized Level 3 Oct 27, 2024 8/9 normalized Level 3 Jan 26, 2025 9/9 normalized Level 3 Apr 27, 2025 9/9 normalized Level 3 Jul 27, 2025 9/9 normalized Level 3 Oct 26, 2025 9/9 normalized Level 3 Jan 25, 2026 9/9 normalized Level 3 Apr 26, 2026 9/9 normalized Level 3 Jul 26, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 24.12%
Current 6.49%
Delta -17.64% Capex Intensity Increased
Previous 2.32%
Current 2.48%
Delta 0.16% Cash Generation Decreased
Previous 50.25%
Current 49.11%
Delta -1.13% Growth Increased
Previous 93.61%
Current 114.20%
Delta 20.59% Inventory Pressure Decreased
Previous 21.82%
Current 7.72%
Delta -14.09% Margin Increased
Previous 74.56%
Current 74.99%
Delta 0.43% Profitability Increased
Previous 62.34%
Current 62.42%
Delta 0.08% R And D Intensity Increased
Previous 9.66%
Current 9.90%
Delta 0.23% Sbc Intensity Increased
Previous 3.57%
Current 3.63%
Delta 0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.